859 related articles for article (PubMed ID: 12924945)
1. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
Bernier-Villamor V; Sampson DA; Matunis MJ; Lima CD
Cell; 2002 Feb; 108(3):345-56. PubMed ID: 11853669
[TBL] [Abstract][Full Text] [Related]
3. Identification of a substrate recognition site on Ubc9.
Lin D; Tatham MH; Yu B; Kim S; Hay RT; Chen Y
J Biol Chem; 2002 Jun; 277(24):21740-8. PubMed ID: 11877416
[TBL] [Abstract][Full Text] [Related]
4. Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex.
Tatham MH; Chen Y; Hay RT
Biochemistry; 2003 Mar; 42(11):3168-79. PubMed ID: 12641448
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme.
Schwarz SE; Matuschewski K; Liakopoulos D; Scheffner M; Jentsch S
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):560-4. PubMed ID: 9435231
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
Ding H; Xu Y; Chen Q; Dai H; Tang Y; Wu J; Shi Y
Biochemistry; 2005 Mar; 44(8):2790-9. PubMed ID: 15723523
[TBL] [Abstract][Full Text] [Related]
7. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
Reverter D; Lima CD
Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
Ahn JH; Xu Y; Jang WJ; Matunis MJ; Hayward GS
J Virol; 2001 Apr; 75(8):3859-72. PubMed ID: 11264375
[TBL] [Abstract][Full Text] [Related]
9. Structure of ubiquitin-conjugating enzyme 9 displays significant differences with other ubiquitin-conjugating enzymes which may reflect its specificity for sumo rather than ubiquitin.
Giraud MF; Desterro JM; Naismith JH
Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):891-8. PubMed ID: 9757105
[TBL] [Abstract][Full Text] [Related]
10. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.
Saitoh H; Sparrow DB; Shiomi T; Pu RT; Nishimoto T; Mohun TJ; Dasso M
Curr Biol; 1998 Jan; 8(2):121-4. PubMed ID: 9427648
[TBL] [Abstract][Full Text] [Related]
11. Ubch9 conjugates SUMO but not ubiquitin.
Desterro JM; Thomson J; Hay RT
FEBS Lett; 1997 Nov; 417(3):297-300. PubMed ID: 9409737
[TBL] [Abstract][Full Text] [Related]
12. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
Wang J; Taherbhoy AM; Hunt HW; Seyedin SN; Miller DW; Miller DJ; Huang DT; Schulman BA
PLoS One; 2010 Dec; 5(12):e15805. PubMed ID: 21209884
[TBL] [Abstract][Full Text] [Related]
14. Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue.
Lee GW; Melchior F; Matunis MJ; Mahajan R; Tian Q; Anderson P
J Biol Chem; 1998 Mar; 273(11):6503-7. PubMed ID: 9497385
[TBL] [Abstract][Full Text] [Related]
15. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
16. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
[TBL] [Abstract][Full Text] [Related]
17. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
Yunus AA; Lima CD
Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
[TBL] [Abstract][Full Text] [Related]
18. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.
Tatham MH; Jaffray E; Vaughan OA; Desterro JM; Botting CH; Naismith JH; Hay RT
J Biol Chem; 2001 Sep; 276(38):35368-74. PubMed ID: 11451954
[TBL] [Abstract][Full Text] [Related]
19. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
20. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification.
Sampson DA; Wang M; Matunis MJ
J Biol Chem; 2001 Jun; 276(24):21664-9. PubMed ID: 11259410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
